The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity
- PMID: 993337
- PMCID: PMC333281
- DOI: 10.1172/JCI108566
The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity
Abstract
Plasma fibrinopeptide A (FPA) concentrations were measured in clinical blood samples incubated in the collecting syringe for different time periods before addition to heparin and Trasylol, and the rate of in vitro generation of FPA was calculated as the mean increment in FPA concentration per minute over the linear portion of the generation curve. 36 normal individuals had a mean plasma FPA level of 0.64 +/- 0.56 pmol/ml and an FPA generation rate of less than 0.5 pmol/ml per min. Clinical samples with elevated plasma FPA levels manifested slow (less than 1 pmol/ml per min) (28 patients) or rapid FPA generation (greater than 1 pmol/ml per min) (33 patients). Slow FPA generation was found in 10/10 patients with venous thrombosis, in 4/4 with aortic aneurysm, and in several patients with acquired hypofibrinogenemia. In one such patient, addition of fibrinogen resulted in rapid FPA generation whereas thrombin addition was without effect. Rapid FPA generation was generally linear, was usually associated with slower fibrinopeptide B generation and was inhibited by parenteral or in vitro heparin. It is thought to reflect increased thrombin activity and was seen in patients with pulmonary embolism, active systemic lupus erythematosus, renal transplant rejection, and after infusion of prothrombin concentrates. The initial rate of FPA cleavage by thrombin at fibrinogen concentrations from 0.05 to 4 mg/ml showed little change between 2 and 4 mg/ml with a Km of 2.99 muM. At a fibrinogen concentration of 2.5 mg/ml the FPA cleavage rate was 49.2 +/- 1.6 nmol/ml per min per U of thrombin. Exogenous thrombin added to normal blood generated 21.7 nmol/ml per U of thrombin FPA in the first minute with a nonlinear pattern reflecting inactivation of thrombin and the presence of alternative substrates. Hence, the thrombin concentration in the blood cannot be calculated from the FPA generation rate. The FPA generation rates in clinical samples with rapid generation (1-28 pmol/ml per min) could be produced by 2 X 10(-5) to 5.6 X 10(-4) thrombin U/ml acting on purified fibrinogen at physiological conditions of pH, ionic strength, and temperature.
Similar articles
-
Measurement of fibrinopeptide A in human blood.J Clin Invest. 1974 Jul;54(1):43-53. doi: 10.1172/JCI107749. J Clin Invest. 1974. PMID: 4600045 Free PMC article. Clinical Trial.
-
Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.Biochemistry. 2003 Oct 28;42(42):12335-48. doi: 10.1021/bi034411e. Biochemistry. 2003. PMID: 14567695
-
Fibrinogen survival and fibrinopeptide A in acute leukemia.Haematologica. 1993 Nov-Dec;78(6 Suppl 2):52-6. Haematologica. 1993. PMID: 8039760
-
Elevated fibrinopeptide A and B levels during thrombolytic therapy: real or artefactual?Thromb Haemost. 1996 Apr;75(4):529-35. Thromb Haemost. 1996. PMID: 8743172 Review.
-
Radioimmunoassays of human fibrinopeptides A and B.Pol Arch Med Wewn. 1978 Jan;59(1):43-8. Pol Arch Med Wewn. 1978. PMID: 349523 Review. No abstract available.
Cited by
-
Soluble Membrane Attack Complex: Biochemistry and Immunobiology.Front Immunol. 2020 Nov 10;11:585108. doi: 10.3389/fimmu.2020.585108. eCollection 2020. Front Immunol. 2020. PMID: 33240274 Free PMC article. Review.
-
Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage.Acta Neurochir (Wien). 1988;91(3-4):120-5. doi: 10.1007/BF01424566. Acta Neurochir (Wien). 1988. PMID: 3407455
-
Problems in the detection of carriers of hemophilia A: the influence of stress and thrombin.Blut. 1978 Jul 14;37(1):37-41. doi: 10.1007/BF01006552. Blut. 1978. PMID: 667368
-
Assessing the impact of different heparin dosing regimens for cardiopulmonary bypass on anticoagulation: the HepDOSE pilot study.Can J Anaesth. 2024 Feb;71(2):234-243. doi: 10.1007/s12630-023-02645-6. Epub 2023 Nov 20. Can J Anaesth. 2024. PMID: 37985627 English.
-
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.J Clin Invest. 1982 Jun;69(6):1212-22. doi: 10.1172/jci110560. J Clin Invest. 1982. PMID: 6282932 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources